Cargando…
Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma
PURPOSE: It has been reported that circulating levels of IgG antibodies against p16, CD25 and FOXP3 proteins were significantly changed in patients with lung cancer, breast cancer and esophageal cancer. However, different peptide fragments appear to trigger different immune responses. This work aime...
Autores principales: | Wang, Jiaxin, Xu, Yangchun, Wang, Yanjun, Zhang, Xuan, Zhang, Guizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897059/ https://www.ncbi.nlm.nih.gov/pubmed/31819529 http://dx.doi.org/10.2147/OTT.S226404 |
Ejemplares similares
-
Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients
por: Lau, K-M, et al.
Publicado: (2007) -
Further study of circulating IgG antibodies to CD25‐derived peptide antigens in nonsmall cell lung cancer
por: Chen, Cairen, et al.
Publicado: (2016) -
Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer
por: Zhao, Huan, et al.
Publicado: (2018) -
Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma
por: Zhang, Na-na, et al.
Publicado: (2015) -
Are CD4(+)CD25(-)Foxp3(+ )cells in untreated new-onset lupus patients regulatory T cells?
por: Yang, Hua-xia, et al.
Publicado: (2009)